Sponsor Oversight Evidence Checklist

The core test

For each important outsourced activity, can the sponsor show what it reviewed, what it decided, who acted, when escalation occurred, and how closure or effectiveness was confirmed?

Governance and decision evidence

• Current responsibility and interface map
• Governance calendar and attendance
• Decisions, rationale where important, owners, and due dates
• Escalation thresholds and routes
• Accepted risks and approval authority
• Evidence that overdue actions are challenged and resolved

CRO and vendor oversight

• Measures connected to meaningful thresholds
• Trends and exceptions, not only average status
• Cross-vendor dependencies
• Recovery plans with accountable owners
• CAPA progress and effectiveness review
• Sponsor follow-up when performance remains weak

Risk, issue, and change control

• Current risk and issue registers
• Clear classification and escalation criteria
• Protocol, country, site, and vendor impacts
• Changes connected to decisions and communications
• Closure evidence that matches the significance of the issue

Medical and safety interfaces

• Defined medical-question categories and intake routes
• Required information for review
• Named decision and escalation roles
• Response expectations and after-hours boundaries
• Documented decisions and follow-up
• Clear interfaces with pharmacovigilance and clinical operations

Inspection-ready continuity

• Oversight records are filed in the expected location
• Operational trackers reconcile with essential records
• Leadership transitions include current risks, decisions, and open actions
• The team can explain how important risks were identified and controlled
• Known gaps have prioritized remediation and accountable follow-through

Use the result

Mark each item as clear, partial, missing, or not applicable. Prioritize gaps that affect participant protection, data reliability, major milestones, or the sponsor’s ability to explain its oversight.

This checklist is a general operational resource. It is not legal or regulatory advice and should be adapted to the protocol, sponsor procedures, service-provider agreements, and applicable requirements.